AI/ML Innovations Inc. Announces Proposed Private Placement
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced a non-brokered private placement offering of up to 20,000,000 units at $0.065 per unit, aiming to raise up to $1,300,000. Each unit consists of one common share and one warrant, exercisable at $0.15 per share for two years. The company plans to use the net proceeds for working capital requirements. The offering is subject to regulatory approvals, including from the Canadian Securities Exchange.
AI/ML Innovations focuses on artificial intelligence and machine learning in the digital health and wellbeing sector. The company has strategic partnerships with Health Gauge (70% owned), Tech2Heal (22% ownership commitment), and AI Rx Inc. (70% owned).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) ha annunciato un'offerta di collocamento privato non intermediato fino a 20.000.000 di unità a 0,065 dollari per unità, con l'obiettivo di raccogliere fino a 1.300.000 dollari. Ogni unità è composta da una azione comune e un warrant, esercitabile a 0,15 dollari per azione per due anni. La società prevede di utilizzare il netto ricavato per esigenze di capitale circolante. L'offerta è soggetta all'approvazione delle autorità competenti, compresa la Borsa Valori Canadese.
AI/ML Innovations si concentra su intelligenza artificiale e apprendimento automatico nel settore della salute digitale e del benessere. L'azienda ha partnership strategiche con Health Gauge (70% di proprietà), Tech2Heal (impegno di proprietà del 22%) e AI Rx Inc. (70% di proprietà).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) ha anunciado una colocación privada no intermediada de hasta 20,000,000 unidades a $0.065 por unidad, con el objetivo de recaudar hasta $1,300,000. Cada unidad consiste en una acción común y un warrant, ejercitable a $0.15 por acción por un período de dos años. La empresa planea utilizar los ingresos netos para necesidades de capital de trabajo. La oferta está sujeta a la aprobación regulatoria, incluida la de la Bolsa de Valores de Canadá.
AI/ML Innovations se enfoca en inteligencia artificial y aprendizaje automático en el sector de salud digital y bienestar. La compañía tiene alianzas estratégicas con Health Gauge (70% de propiedad), Tech2Heal (compromiso de propiedad del 22%) y AI Rx Inc. (70% de propiedad).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB)는 중개인 없는 사모 배정을 통해 20,000,000 유니트를 개당 0.065달러에 제공하여 최대 1,300,000달러를 모금할 계획이라고 발표했습니다. 각 유니트는 공통 주식과 두 년간 주당 0.15달러로 행사가 가능한 워런트로 구성됩니다. 회사는 순 수익을 운전 자본 요구사항에 사용할 계획입니다. 이 오퍼링은 캐나다 증권 거래소를 포함한 규제 승인을 받는 조건입니다.
AI/ML Innovations는 디지털 건강 및 웰니스 분야에서 인공지능과 기계 학습에 중점을 두고 있습니다. 이 회사는 Health Gauge (70% 소유), Tech2Heal (22% 소유 약속), AI Rx Inc. (70% 소유)와 전략적 파트너십을 맺고 있습니다.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) a annoncé une émission privée sans courtier d'un maximum de 20.000.000 d'unités à 0,065 $ par unité, visant à lever jusqu'à 1.300.000 $. Chaque unité se compose d'une action ordinaire et d'un warrant, exerçable à 0,15 $ par action pendant deux ans. La société prévoit d'utiliser le produit net pour besoins en fonds de roulement. L'offre est soumise aux approbations réglementaires, y compris celle de la Bourse canadienne des valeurs mobilières.
AI/ML Innovations se concentre sur l'intelligence artificielle et l'apprentissage automatique dans le secteur de la santé numérique et du bien-être. L'entreprise a des partenariats stratégiques avec Health Gauge (70 % de propriété), Tech2Heal (engagement de propriété de 22 %) et AI Rx Inc. (70 % de propriété).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) hat ein nicht vermittelte Privatplatzierung von bis zu 20.000.000 Einheiten zu einem Preis von 0,065 $ pro Einheit angekündigt, mit dem Ziel, bis zu 1.300.000 $ zu sammeln. Jede Einheit besteht aus einer Stammaktie und einem Warrant, der für zwei Jahre zu 0,15 $ pro Aktie ausgeübt werden kann. Das Unternehmen plant, den Nettoprocess für Betriebs- und Liquiditätsanforderungen zu verwenden. Das Angebot unterliegt behördlichen Genehmigungen, einschließlich der von der Canadian Securities Exchange.
AI/ML Innovations konzentriert sich auf künstliche Intelligenz und maschinelles Lernen im Bereich digitale Gesundheit und Wohlbefinden. Das Unternehmen hat strategische Partnerschaften mit Health Gauge (70% im Besitz), Tech2Heal (22% Eigentumsengagement) und AI Rx Inc. (70% im Besitz).
- Potential to raise up to $1,300,000 in capital
- Warrants provide potential for additional future funding at $0.15 per share
- Proceeds to be used for working capital, potentially strengthening the company's financial position
- Potential dilution of existing shareholders' ownership
- Offering price of $0.065 per unit may be below current market price
- Success of the private placement is not guaranteed and subject to market conditions and approvals
Up to 20,000,000 Units to be Issued at
VICTORIA, BC / ACCESSWIRE / October 21, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it intends to complete a non-brokered private placement offering of up to 20,000,000 units ("Units") at a price of
The Common Shares and Warrants comprising the Units will be subject to a four-month and one day hold period in accordance with the policies of the CSE and applicable securities legislation.
The Company intends to use net proceeds of the Private Placement for working capital requirements.
The Company will pay a finder's fee to qualified finders who assist in selling the Units, in cash or securities or a combination of both, as permitted by CSE policy and applicable securities laws.
The Private Placement is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including approval from the Canadian Securities Exchange.
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: AI/ML Innovations, Inc.
View the original press release on accesswire.com
FAQ
What is the size and price of AI/ML Innovations Inc.'s (AIMLF) proposed private placement?
What are the terms of the warrants included in AI/ML Innovations Inc.'s (AIMLF) private placement units?
How does AI/ML Innovations Inc. (AIMLF) plan to use the proceeds from the private placement?
What is the focus of AI/ML Innovations Inc.'s (AIMLF) business operations?
